Experiment 814790

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationMURPHY,WK: BURGRESS,MA: VALDIVIESO,M: LIVINGSTON,RB: BODEY,GP: FREIREICH,EJ:. (1978). PHASE I CLINICAL EVALUATION OF ANGUIDINE.. 62()
Amount utilized
Compound isolated
DiseasePHASE I CLINICAL EVALUATION INVOLVING 39 PATIENTS DAILY DOSING FOR 5 DAYS AT 2-WEEK INTERVALS TOXIC SYMPTOMS WERE NAUSEA,VOMITING HYPTOTNSION,DIARRHEA,CHILLS,FEVER,CNS EFFECTS,BURNING ERYTHEMA ALSO,STOMATITIS,SHORTNESS OF BREATH,MODERATE MYELOSUPPRESION AND IMPAIRMENT OF LIVER FUNCTION(1 CS)
Dose amount0.1 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES